H P Chase

Summary

Affiliation: University of Colorado Health Sciences Center
Country: USA

Publications

  1. ncbi request reprint Post-prandial glucose excursions following four methods of bolus insulin administration in subjects with type 1 diabetes
    H P Chase
    Department of Paediatrics, Barbara Davis Center, University of Colorado Health Sciences Center, Denver, CO 80262, USA
    Diabet Med 19:317-21. 2002
  2. doi request reprint Timing of meal insulin boluses to achieve optimal postprandial glycemic control in patients with type 1 diabetes
    Erin Cobry
    Barbara Davis Center for Childhood Diabetes, Aurora, Colorado 80045, USA
    Diabetes Technol Ther 12:173-7. 2010
  3. ncbi request reprint Reduced hypoglycemic episodes and improved glycemic control in children with type 1 diabetes using insulin glargine and neutral protamine Hagedorn insulin
    H Peter Chase
    Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Science Center, Denver, Colorado, USA
    J Pediatr 143:737-40. 2003
  4. ncbi request reprint Elevated C-reactive protein levels in the development of type 1 diabetes
    H Peter Chase
    Department of Pediatrics, The Barbara Davis Center for Childhood Diabetes, Denver, Colorado, USA
    Diabetes 53:2569-73. 2004
  5. ncbi request reprint The use of insulin pumps with meal bolus alarms in children with type 1 diabetes to improve glycemic control
    H Peter Chase
    Department of Pediatrics, University of Colorado Health Sciences Center, Barbara Davis Center for Childhood Diabetes, Mail Stop A140, P O Box 6511, Aurora, CO 80045 6511, USA
    Diabetes Care 29:1012-5. 2006
  6. doi request reprint Insulin glargine versus intermediate-acting insulin as the basal component of multiple daily injection regimens for adolescents with type 1 diabetes mellitus
    H Peter Chase
    Barbara Davis Center, University of Colorado, Aurora, CO 80045 6511, USA
    J Pediatr 153:547-53. 2008
  7. ncbi request reprint Modem transmission of glucose values reduces the costs and need for clinic visits
    H Peter Chase
    Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, USA
    Diabetes Care 26:1475-9. 2003
  8. ncbi request reprint Redefining the clinical remission period in children with type 1 diabetes
    H Peter Chase
    University of Colorado Health Sciences Center, Denver, CO 80262, USA
    Pediatr Diabetes 5:16-9. 2004
  9. ncbi request reprint Continuous subcutaneous glucose monitoring in children with type 1 diabetes
    H P Chase
    Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, Denver, Colorado 80262, USA
    Pediatrics 107:222-6. 2001
  10. ncbi request reprint The impact of the diabetes control and complications trial and humalog insulin on glycohemoglobin levels and severe hypoglycemia in type 1 diabetes
    H P Chase
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, USA
    Diabetes Care 24:430-4. 2001

Research Grants

Collaborators

Detail Information

Publications59

  1. ncbi request reprint Post-prandial glucose excursions following four methods of bolus insulin administration in subjects with type 1 diabetes
    H P Chase
    Department of Paediatrics, Barbara Davis Center, University of Colorado Health Sciences Center, Denver, CO 80262, USA
    Diabet Med 19:317-21. 2002
    ..To determine if one method of short-acting insulin bolus administration is superior to other methods in managing a meal high in carbohydrates, calories and fat...
  2. doi request reprint Timing of meal insulin boluses to achieve optimal postprandial glycemic control in patients with type 1 diabetes
    Erin Cobry
    Barbara Davis Center for Childhood Diabetes, Aurora, Colorado 80045, USA
    Diabetes Technol Ther 12:173-7. 2010
    ..This study determined the optimal timing of insulin bolus administration in relation to meal consumption in adolescents and adults with type 1 diabetes...
  3. ncbi request reprint Reduced hypoglycemic episodes and improved glycemic control in children with type 1 diabetes using insulin glargine and neutral protamine Hagedorn insulin
    H Peter Chase
    Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Science Center, Denver, Colorado, USA
    J Pediatr 143:737-40. 2003
    ..The numbers of nonsevere and severe hypoglycemic events, hemoglobin A1c values, body weight, and daily insulin dose were recorded at each clinic visit...
  4. ncbi request reprint Elevated C-reactive protein levels in the development of type 1 diabetes
    H Peter Chase
    Department of Pediatrics, The Barbara Davis Center for Childhood Diabetes, Denver, Colorado, USA
    Diabetes 53:2569-73. 2004
    ..The elevated CRP levels may provide an additional marker for risk of progression to type 1 diabetes...
  5. ncbi request reprint The use of insulin pumps with meal bolus alarms in children with type 1 diabetes to improve glycemic control
    H Peter Chase
    Department of Pediatrics, University of Colorado Health Sciences Center, Barbara Davis Center for Childhood Diabetes, Mail Stop A140, P O Box 6511, Aurora, CO 80045 6511, USA
    Diabetes Care 29:1012-5. 2006
    ..The aim of this study was to determine whether the use of meal bolus alarms would result in fewer missed meal boluses per week in youth with type 1 diabetes using continuous subcutaneous insulin infusion (CSII) therapy...
  6. doi request reprint Insulin glargine versus intermediate-acting insulin as the basal component of multiple daily injection regimens for adolescents with type 1 diabetes mellitus
    H Peter Chase
    Barbara Davis Center, University of Colorado, Aurora, CO 80045 6511, USA
    J Pediatr 153:547-53. 2008
    ....
  7. ncbi request reprint Modem transmission of glucose values reduces the costs and need for clinic visits
    H Peter Chase
    Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, USA
    Diabetes Care 26:1475-9. 2003
    ..To determine whether modem technology allows for effective management of type 1 diabetes when used in lieu of a clinic visit...
  8. ncbi request reprint Redefining the clinical remission period in children with type 1 diabetes
    H Peter Chase
    University of Colorado Health Sciences Center, Denver, CO 80262, USA
    Pediatr Diabetes 5:16-9. 2004
    ..To redefine the clinical remission period for different aged children receiving the current standard of diabetes care...
  9. ncbi request reprint Continuous subcutaneous glucose monitoring in children with type 1 diabetes
    H P Chase
    Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, Denver, Colorado 80262, USA
    Pediatrics 107:222-6. 2001
    ....
  10. ncbi request reprint The impact of the diabetes control and complications trial and humalog insulin on glycohemoglobin levels and severe hypoglycemia in type 1 diabetes
    H P Chase
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, USA
    Diabetes Care 24:430-4. 2001
    ....
  11. ncbi request reprint Long-term efficacy of humalog in subjects with Type 1 diabetes mellitus
    S K Garg
    Barbara Davis Center for Childhood Diabetes, Department of Paediatrics, University of Colorado Health Sciences Center, Denver, USA
    Diabet Med 16:384-7. 1999
    ..To evaluate the long-term effectiveness of Humalog insulin in lowering post meal glucose excursions...
  12. ncbi request reprint Use of the GlucoWatch biographer in children with type 1 diabetes
    H Peter Chase
    Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, Colorado, USA
    Pediatrics 111:790-4. 2003
    ..To determine whether use of the GlucoWatch biographer improves glucose control in children and adolescents with type 1 diabetes...
  13. ncbi request reprint Improved glycemic control after long-term insulin pump use in pediatric patients with type 1 diabetes
    Laura Scrimgeour
    Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Aurora, CO 80045, USA
    Diabetes Technol Ther 9:421-8. 2007
    ..There are currently few data available on the long-term use of continuous subcutaneous insulin infusion (CSII) (insulin pump) therapy in children...
  14. ncbi request reprint Continuous subcutaneous insulin infusion therapy for children and adolescents: an option for routine diabetes care
    A K Maniatis
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA
    Pediatrics 107:351-6. 2001
    ..CONCLUSIONS: CSII therapy is an appropriate option for some children in routine pediatric diabetes care. It can effectively decrease the HbA(1c) and reduce hypoglycemic episodes, without producing an abnormal increase in BMI...
  15. doi request reprint Use of a subcutaneous injection port to improve glycemic control in children with type 1 diabetes
    Patricia Burdick
    Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Aurora, CO, USA
    Pediatr Diabetes 10:116-9. 2009
    ..To determine if use of an injection port, the Insuflon, would help to improve glycemic control in youth with type 1 diabetes (TID) who were in suboptimal glycemic control (hemoglobin A1c, HbA1c >8.0%)...
  16. pmc Missed insulin boluses for snacks in youth with type 1 diabetes
    Brandon W Vanderwel
    University of Colorado, Aurora, Colorado, USA
    Diabetes Care 33:507-8. 2010
    ..3 vs. 1.1 mg/dl per minute; P < 0.001). CONCLUSIONS This study shows that afternoon snacks without insulin boluses are common and result in significantly higher glucose excursions than snacks with insulin administration...
  17. pmc Diabetic subjects diagnosed through the Diabetes Prevention Trial-Type 1 (DPT-1) are often asymptomatic with normal A1C at diabetes onset
    Taylor M Triolo
    University of Colorado Denver, Barbara Davis Center for Childhood Diabetes, Aurora, Colorado, USA
    Diabetes Care 32:769-73. 2009
    ..Metabolic tests and the presence of symptoms were described at diabetes onset during the Diabetes Prevention Trial-Type 1 (DPT-1)...
  18. doi request reprint A pilot trial of pramlintide home usage in adolescents with type 1 diabetes
    Christopher M Kishiyama
    Department of Pediatrics, University of Colorado, Aurora, Colorado 80045, USA
    Pediatrics 124:1344-7. 2009
    ..The objective of this study was to evaluate the safety and efficacy of home pramlintide use in adolescents with type 1 diabetes...
  19. doi request reprint Continuous glucose monitoring in youth with type 1 diabetes
    R Paul Wadwa
    Barbara Davis Center for Childhood Diabetes, Aurora, Colorado 80045, USA
    Diabetes Technol Ther 11:S83-91. 2009
    ..In the future, CGM use in youth may couple with insulin pump technology to create a "closed-loop" system in which the CGM device will direct insulin administration without user input...
  20. doi request reprint Factors affecting improved glycaemic control in youth using insulin pumps
    J Wilkinson
    University of Colorado, Aurora, CO, USA
    Diabet Med 27:1174-7. 2010
    ..The purpose of this study was to evaluate factors associated with insulin pump therapy resulting in lower HbA(1c) levels in young people with Type 1 diabetes mellitus...
  21. ncbi request reprint Correlation of fingerstick blood glucose measurements with GlucoWatch biographer glucose results in young subjects with type 1 diabetes
    S K Garg
    Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver 80262, USA
    Diabetes Care 22:1708-14. 1999
    ..Redwood City, CA) with capillary blood glucose values that were determined 1) in a controlled outpatient clinic setting and 2) in a home setting...
  22. ncbi request reprint Mixing rapid-acting insulin analogues with insulin glargine in children with type 1 diabetes mellitus
    Rosanna Fiallo-Scharer
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, Colorado, USA
    J Pediatr 148:481-4. 2006
    ..To determine whether mixing insulin glargine (IG) with a rapid-acting insulin (RAI) analogue in the same syringe had any deleterious effects on glycemic control in children with type 1 diabetes mellitus...
  23. ncbi request reprint Prevention strategies for type 1 diabetes
    Christopher M Kishiyama
    The Barbara Davis Center for Childhood Diabetes, Denver, CO, USA
    Rev Endocr Metab Disord 7:215-24. 2006
    ..This review article describes the past, current and upcoming strategies for diabetes prevention for patients at risk for developing autoimmunity, after antibody production, and patients with new onset diabetes...
  24. pmc Pre-type 1 diabetes dysmetabolism: maximal sensitivity achieved with both oral and intravenous glucose tolerance testing
    Jennifer M Barker
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, CO 80262, USA
    J Pediatr 150:31-36.e6. 2007
    ....
  25. ncbi request reprint The role of continuous glucose sensors in diabetes care
    Satish K Garg
    Department of Medicine, University of Colorado Health Sciences Center, 4200 East 9th Avenue, Campus Box B 140, Denver, CO 80262, USA
    Endocrinol Metab Clin North Am 33:163-73, x-xi. 2004
  26. ncbi request reprint Omega-3 polyunsaturated fatty acid intake and islet autoimmunity in children at increased risk for type 1 diabetes
    Jill M Norris
    Department of Preventive Medicine and Biostatistics, University of Colorado at Denver and Health Sciences Center, Denver, CO 80262, USA
    JAMA 298:1420-8. 2007
    ..Cod liver oil supplements in infancy have been associated with a decreased risk of type 1 diabetes mellitus in a retrospective study...
  27. doi request reprint Use of CoZmonitor in youth with type 1 diabetes
    Erin Cobry
    Department of Pediatrics, Barbara Davis Center, University of Colorado Health Sciences Center, Aurora, CO 80045 6511, USA
    Pediatr Diabetes 9:148-51. 2008
    ..The purpose of this study was to evaluate the effectiveness of directly integrating self-monitoring blood glucose (BG) information with insulin pump therapy on overall glycemic control...
  28. pmc The use of insulin pumps in youth with type 1 diabetes
    David M Maahs
    University of Colorado Barbara Davis Center for Childhood Diabetes, 1775 Aurora Court, Aurora, CO 80045, USA
    Diabetes Technol Ther 12:S59-65. 2010
    ..Finally, diabetes management in the 21st century, in which pump therapy is combined with continuous glucose monitoring, and its potential for a closed-loop pancreas are presented...
  29. ncbi request reprint Missed insulin meal boluses and elevated hemoglobin A1c levels in children receiving insulin pump therapy
    Jonathan Burdick
    Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, Colorado, USA
    Pediatrics 113:e221-4. 2004
    ..To identify possible causes of suboptimal glycemic control (ascertained by hemoglobin A1c [HbA1c] level) in youths using insulin pump therapy...
  30. ncbi request reprint Glycemic parameters with multiple daily injections using insulin glargine versus insulin pump
    Satish K Garg
    Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA
    Diabetes Technol Ther 6:9-15. 2004
    ..However, costs and episodes of diabetic ketoacidosis are significantly higher for insulin pump users...
  31. ncbi request reprint Improved glycemic control without an increase in severe hypoglycemic episodes in intensively treated patients with type 1 diabetes receiving morning, evening, or split dose insulin glargine
    Satish K Garg
    Department of Medicine, University of Colorado Health Sciences Center, Denver, CO 80262, USA
    Diabetes Res Clin Pract 66:49-56. 2004
    ..Sixty-three subjects were taking glargine in the morning, 125 were taking glargine in the evening, and 104 were splitting the glargine dose between the morning and evening...
  32. ncbi request reprint Continuous glucose monitoring in type 1 diabetes
    Stuart A Weinzimer
    Yale University School of Medicine, Department of Pediatrics, PO Box 208064, 333 Cedar Street, New Haven, CT 06520, USA
    Curr Diab Rep 4:95-100. 2004
    ..The current "state of the art" of this technology, including accuracy, performance in clinical trials, limitations, and recommendations for use, is discussed for the two currently approved continuous glucose monitoring devices...
  33. ncbi request reprint Inflammatory markers and diabetic retinopathy in type 1 diabetes
    Kenneth E Izuora
    Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, 4200 East 9th Ave, Box B 140, Denver, CO, USA
    Diabetes Care 28:714-5. 2005
  34. doi request reprint Continuous glucose monitoring in youth with type 1 diabetes: 12-month follow-up of the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial
    H Peter Chase
    Barbara Davis Center, Denver, Colorado, USA
    Diabetes Technol Ther 12:507-15. 2010
    ..The use of continuous glucose monitoring (CGM) in the pediatric population is not well characterized. We have evaluated the use of CGM over a 12-month interval in youth with type 1 diabetes (TID) and have provided a description of CGM use...
  35. ncbi request reprint Predictors of acute complications in children with type 1 diabetes
    Arleta Rewers
    Pediatric Emergency Medicine, Department of Pediatrics, University of Colorado, School of Medicine, The Children s Hospital, Denver, CO 80218, USA
    JAMA 287:2511-8. 2002
    ..Diabetic ketoacidosis and severe hypoglycemia are acute complications of type 1 diabetes that are related, respectively, to insufficient or excessive insulin treatment. However, little is known about additional modifiable risk factors...
  36. doi request reprint Pramlintide lowered glucose excursions and was well-tolerated in adolescents with type 1 diabetes: results from a randomized, single-blind, placebo-controlled, crossover study
    H Peter Chase
    Barbara Davis Center for Childhood Diabetes, University of Colorado, Aurora, CO 80045 6511, USA
    J Pediatr 155:369-73. 2009
    ..To evaluate the pharmacokinetics, pharmacodynamics, safety, and tolerability of pramlintide in treating adolescents with type 1 diabetes...
  37. ncbi request reprint In utero dietary exposures and risk of islet autoimmunity in children
    Carolyn M Fronczak
    Department of Preventive Medicine and Biometrics, University of Colorado Health Sciences Center, Denver, Colorado, USA
    Diabetes Care 26:3237-42. 2003
    ..The goal of this study was to examine whether maternal dietary intake of vitamin D, omega-3 fatty acids, and omega-6 fatty acids during pregnancy is associated with the appearance of islet autoimmunity (IA) in offspring...
  38. ncbi request reprint Don't take away my pump! Switching to injections may cause problems
    H Peter Chase
    University of Colorado Health Sciences Center, Denver, Colorado, USA
    Diabetes Forecast 58:55-6. 2005
  39. pmc Preventing post-exercise nocturnal hypoglycemia in children with type 1 diabetes
    Craig E Taplin
    University of Colorado, Barbara Davis Center for Childhood Diabetes, Aurora, CO 80045, USA
    J Pediatr 157:784-8.e1. 2010
    ..To determine the effects of reducing overnight basal insulin or a bedtime dose of terbutaline on nocturnal blood glucose (BG) nadir and hypoglycemia after exercise in children with type 1 diabetes mellitus...
  40. ncbi request reprint First-phase insulin release during the intravenous glucose tolerance test as a risk factor for type 1 diabetes
    H P Chase
    Barbara Davis Center, University of Colorado Health Sciences Center, Denver, USA
    J Pediatr 138:244-9. 2001
    ..CONCLUSION: FPIR in the IV-GTT correlates strongly with risk factors for development of type 1 diabetes...
  41. ncbi request reprint Clinical trials for the prevention of type 1 diabetes
    H Peter Chase
    Barbara Davis Center for Childhood Diabetes, University of Colorado, Health Sciences Center, Denver, USA
    Adv Exp Med Biol 552:291-305. 2004
  42. ncbi request reprint Bedside monitoring of blood beta-hydroxybutyrate levels in the management of diabetic ketoacidosis in children
    Arleta Rewers
    Pediatric Emergency Medicine, Department of Pediatrics, University of Colorado at Denver and Health Sciences Center, Denver, Colorado 80218, USA
    Diabetes Technol Ther 8:671-6. 2006
    ..The purpose of this study was to evaluate if bedside monitoring of blood beta-OHB levels can simplify management of DKA through elimination of superfluous laboratory monitoring...
  43. ncbi request reprint Detection of ketosis and monitoring of diabetic ketoacidosis
    H Peter Chase
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, USA
    Manag Care 13:5-6; discussion 19-21. 2004
  44. ncbi request reprint Cost-effectiveness of use of the GlucoWatch Biographer in children and adolescents with type 1 diabetes: a preliminary analysis based on a randomized controlled trial
    Richard C Eastman
    Cygnus, Inc, 400 Penobscot Drive, Redwood City, California 94063, USA
    Pediatr Diabetes 4:82-6. 2003
    ..To conduct a preliminary analysis of the cost-effectiveness of the use of the GlucoWatch Biographer in the management of type 1 diabetes in children and adolescents...
  45. pmc Impact of exercise on overnight glycemic control in children with type 1 diabetes mellitus
    Eva Tsalikian
    DirectNet Coordinating Center, Jaeb Center for Health Research, Tampa, Florida 33647, USA
    J Pediatr 147:528-34. 2005
    ..To examine the effect of exercise on overnight hypoglycemia in children with type 1 diabetes mellitus (T1DM)...
  46. doi request reprint Continuous glucose monitoring and intensive treatment of type 1 diabetes
    William V Tamborlane
    N Engl J Med 359:1464-76. 2008
    ..The value of continuous glucose monitoring in the management of type 1 diabetes mellitus has not been determined...
  47. pmc Accuracy of newer-generation home blood glucose meters in a Diabetes Research in Children Network (DirecNet) inpatient exercise study
    Stuart A Weinzimer
    DirecNet Coordinating Center, Jaeb Center for Health Research, Tampa, FL 33647, USA
    Diabetes Technol Ther 7:675-80; discussion 681-3. 2005
    ..The objective of this study was to assess how the accuracy of the FreeStyle Flash (Abbott Diabetes Care, Alameda, CA) meter compares with that of the One Touch Ultra (Lifescan, Milpitas, CA) home glucose meter (HGM)...
  48. ncbi request reprint Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1
    Jay M Sosenko
    Division of Endocrinology, University of Miami, PO Box 016960 D110, Miami, FL 33101, USA
    Diabetes Care 29:643-9. 2006
    ..The goal of this study was to utilize data from the Diabetes Prevention Trial-Type 1 (DPT-1) to obtain a picture of the metabolic progression to type 1 diabetes over a period of approximately 2.5 years before its diagnosis...
  49. ncbi request reprint A randomized multicenter trial comparing the GlucoWatch Biographer with standard glucose monitoring in children with type 1 diabetes
    H Peter Chase
    DirecNet Coordinating Center, Jaeb Center for Health Research, 15310 Amberly Drive, Suite 350, Tampa, FL 33647, USA
    Diabetes Care 28:1101-6. 2005
    ..This study assesses whether use of the GlucoWatch G2 Biographer (GW2B) in addition to standard glucose monitoring lowers HbA(1c) and reduces hypoglycemia compared with standard glucose monitoring alone...
  50. ncbi request reprint Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1
    Jay S Skyler
    University of Miami, PO Box 016960 D 110, Miami, FL 33101 6960, USA
    Diabetes Care 28:1068-76. 2005
    ..This randomized, double-masked, placebo-controlled clinical trial tested whether oral insulin administration could delay or prevent type 1 diabetes in nondiabetic relatives at risk for diabetes...
  51. ncbi request reprint Nocturnal hypoglycemia--an unrelenting problem
    H Peter Chase
    J Clin Endocrinol Metab 91:2038-9. 2006
  52. ncbi request reprint Treatment of adolescents with type 1 diabetes mellitus
    Satish Garg
    J Pediatr Endocrinol Metab 17:805-6. 2004
  53. ncbi request reprint Increasing the accuracy of oral glucose tolerance testing and extending its application to individuals with normal glucose tolerance for the prediction of type 1 diabetes: the Diabetes Prevention Trial-Type 1
    Jay M Sosenko
    Division of Endocrinology, University of Miami, P O Box 016960 D110, Miami, FL 33101, USA
    Diabetes Care 30:38-42. 2007
    ....
  54. ncbi request reprint Glycemic control in prepubertal years
    H Peter Chase
    Diabetes Care 26:1304-5. 2003
  55. pmc Lack of accuracy of continuous glucose sensors in healthy, nondiabetic children: results of the Diabetes Research in Children Network (DirecNet) accuracy study
    Nelly Mauras
    DirecNet Coordinating Center, Tampa, Florida, USA
    J Pediatr 144:770-5. 2004
    ..Study design Fifteen healthy children (aged 9-17 years, 11 boys) wore a GW2B and a CGMS during a 24-hour period, and reference serum glucose was measured hourly during the day and half-hourly overnight...
  56. pmc Use of the DirecNet Applied Treatment Algorithm (DATA) for diabetes management with a real-time continuous glucose monitor (the FreeStyle Navigator)
    Bruce Buckingham
    Pediatr Diabetes 9:142-7. 2008
    ..The DATA provides algorithms for making diabetes management decisions using glucose values: (i) in real time which include the direction and rate of change of glucose levels, and (ii) retrospectively based on downloaded sensor data...
  57. ncbi request reprint How should we interpret "real life" conditions
    Richard C Eastman
    Pediatr Diabetes 4:59. 2003

Research Grants2

  1. Glucose Sensors in Children with Type I Diabetes
    H Chase; Fiscal Year: 2006
    ..Quality of Life and Fear of Hypoglycemia Questionnaires will be used to evaluate psychological factors in both the factors in both the feasibility and the two-year trials. ..